Properties
Description
Etoricoxib D4 blocks the COX enzymes from converting arachidonic acid to prostaglandins, thereby reducing inflammatory reactions.
Molecular Formula
C18H11D4ClN2O2S
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Etoricoxib D4 is a deuterated form of Etoricoxib used to study COX-2 inhibition and anti-inflammatory effects with improved pharmacokinetic properties.